Insulin Delivery Devices Market in the US – Size, Forecast, and Competitive Landscape: Explore Beta Bionics’ US Potential

Market Outlook: Insulin Delivery Devices Market in the US 2025-2029

The insulin delivery devices market is growing rapidly, driven by the increasing prevalence of diabetes and advancements in technologies such as insulin pens, pumps, and smart devices that offer more accurate, convenient, and efficient ways to manage blood glucose levels. The market is expected to grow by USD 4-7 billion at a CAGR of 7%-9% between 2025 and 2029. Exact values for this market can be accessed upon purchasing the report. Key companies in this market include:

• Medtronic
• Tandem Diabetes Care
• Smiths Medical
• Abbott Laboratories
• Roche Diabetes Care
• Others

IPO Company Overview: Beta Bionics in the US insulin delivery devices market

Beta Bionics, Inc. recently launched its IPO on the Nasdaq Global Market in January 2025 under the ticker symbol BBNX, creating a new opportunity for investors. Beta Bionics is a pioneering medical device company focused on revolutionizing diabetes management through its innovative insulin delivery solutions. Known for its flagship product, the iLet Bionic Pancreas, Beta Bionics is developing advanced, automated insulin delivery systems that aim to simplify and improve the lives of individuals with diabetes. By integrating cutting-edge technologies such as continuous glucose monitoring and artificial intelligence, the iLet Bionic Pancreas delivers precise, real-time insulin doses to maintain optimal blood glucose levels, offering a promising solution for both Type 1 and Type 2 diabetes patients.

Market Segmentation: How is the US insulin delivery devices market segmented?

Device Type

• Insulin Pumps
• Insulin Pens
• Syringes
• Inhaled Insulin
• Continuous Glucose Monitors (CGMs)

Insulin pumps are the leading device type, as they offer a more precise and continuous delivery of insulin, providing greater flexibility and control for individuals with diabetes, especially those with Type 1 diabetes, driving strong demand for advanced, automated solutions like the hybrid closed-loop systems.

End-User

• Diabetes Patients
• Hospitals and Clinics

Diabetes patients represent the leading subsegment, as they rely heavily on insulin delivery devices for daily management of their condition, creating significant demand for advanced insulin pumps and CGMs to enhance glucose control and improve quality of life.

Investment Opportunities: Why explore the US insulin delivery devices market with Technavio?

Recent developments in the insulin delivery devices market in the US reflect significant advancements in technology and increased demand for more precise and convenient diabetes management solutions. One of the most notable trends is the growing adoption of insulin pumps and continuous glucose monitoring (CGM) systems, which offer a more integrated and automated approach to insulin delivery. Companies like Medtronic, Tandem Diabetes Care, and Beta Bionics are leading the way with next-generation insulin pumps and hybrid closed-loop systems, which use real-time data from CGMs to adjust insulin delivery automatically. Additionally, the integration of smart technology and AI into insulin pumps is enabling more personalized treatment plans and remote monitoring, making diabetes management more accessible and user-friendly. The emergence of wearable insulin delivery devices that sync with smartphones and cloud-based platforms has further driven innovation and convenience for patients.

Another key development in the market is the regulatory advancements and growing support for inhaled insulin products, offering a non-injection alternative for insulin delivery. Products like Afrezza, which delivers insulin via inhalation, are gaining attention as a viable option for patients seeking a more discreet and pain-free solution for insulin administration. Moreover, there has been a shift towards expanding access to insulin delivery devices through insurance coverage and more affordable pricing models, which has increased their adoption among both Type 1 and Type 2 diabetes patients. As patient demand for more efficient, automated, and less invasive solutions continues to grow, the insulin delivery devices market is expected to experience sustained innovation and expansion, with ongoing efforts to improve device affordability and functionality.

Market Dynamics: What factors are influencing the insulin delivery devices market in the US?

Drivers:

The insulin delivery devices market in the US is primarily driven by the increasing prevalence of diabetes, particularly Type 1 and Type 2 diabetes, and the growing need for more effective and convenient diabetes management solutions. As patients seek better control over their blood glucose levels, advanced insulin pumps, continuous glucose monitors (CGMs), and smart insulin delivery systems are in high demand. Technological advancements, such as hybrid closed-loop systems and artificial pancreas systems, have made insulin delivery more automated and precise, providing greater comfort and flexibility for users, which in turn, accelerates market growth. Additionally, the increasing awareness about diabetes management and improvements in healthcare access and insurance coverage are fueling the adoption of these devices.

Trends:

One of the leading trends in the US insulin delivery devices market is the rise of smart insulin delivery systems, which combine insulin pumps and continuous glucose monitoring (CGM) to provide real-time data and automated insulin adjustments. These devices are becoming more user-friendly, with enhanced smartphone integration, cloud-based monitoring, and AI and machine learning algorithms that personalize treatment plans. Another key trend is the growth of wearable insulin devices, designed for greater comfort and convenience, with a focus on minimizing the invasiveness of traditional insulin injections. As a result, more patients are shifting toward solutions that offer continuous glucose monitoring and insulin delivery in one integrated device.

Opportunities:

The insulin delivery devices market offers several opportunities, particularly in expanding access to cutting-edge solutions for both Type 1 and Type 2 diabetes patients. With the rise in diabetes diagnoses and an increasing focus on early intervention and preventive care, the demand for insulin pumps, CGMs, and combination devices is expected to continue growing. Additionally, the increasing popularity of non-invasive insulin delivery methods, such as inhaled insulin, presents an opportunity to cater to patients seeking alternatives to traditional injection-based systems. The continued development of digital health solutions and telemedicine also offers opportunities to enhance the connectivity and remote monitoring features of insulin delivery devices, making it easier for healthcare providers to track patient progress and adjust treatment plans.

Challenges:

Despite the market's growth, several challenges remain for the insulin delivery devices sector in the US One of the primary hurdles is the cost of advanced insulin delivery devices, which can be prohibitively expensive for many patients, even with insurance coverage. Additionally, the complexity of integrating multiple technologies (insulin pumps, CGMs, and smart devices) may pose challenges in terms of user training and adoption. Regulatory approval processes and safety concerns related to device malfunctions, such as inaccurate insulin delivery or data errors, also present barriers to market expansion. Finally, privacy and security concerns regarding the use of cloud-based and smartphone-integrated devices raise questions about data protection, further complicating the market's growth trajectory.

Investment Questions: Topics to consider when investing in the insulin delivery devices market in the US

What is the market growth potential?
Investors should evaluate the projected growth of the insulin delivery devices market, considering factors like the increasing prevalence of diabetes, technological advancements, and the demand for more efficient, automated solutions.

How do regulatory requirements affect the market?
Understanding the regulatory landscape for insulin delivery devices is crucial, as companies must navigate FDA approvals, safety standards, and ongoing compliance requirements to bring new products to market.

What are the adoption rates of advanced technologies?
Investors should consider how quickly patients and healthcare providers are adopting emerging technologies, such as insulin pumps with continuous glucose monitoring (CGM) systems and smart insulin delivery systems, which could significantly influence market growth.

How is pricing and reimbursement affecting market adoption?
The cost of insulin delivery devices, along with insurance reimbursement policies, can impact patient access and the overall growth of the market. Investors should assess how these factors are evolving and how companies are addressing affordability concerns.

What are the privacy and security concerns surrounding connected devices?
With the rise of smart, cloud-connected insulin delivery systems, data privacy and cybersecurity are important issues. Investors should consider how companies are addressing these concerns to build trust and ensure the protection of sensitive patient information.

For a detailed analysis of the insulin delivery devices market in the US, buy the full report

Technavio Report Insights: How Can Technavio Reports Help Investors Make Better Business Decisions?

Key Features of a Technavio Report: 

• Comprehensive Market Analysis: Provides a detailed overview of the insulin delivery devices market in the US, including market size, growth rate, segmentation, and regional analysis. 

• In-Depth Competitive Landscape: Offers insights into the competitive dynamics, market share and positioning, and product offerings of key players. 

• Future Market Trends: Identifies emerging trends and opportunities that can shape the future of the market. 

• Detailed Segmentation: Breaks down the market into various segments to help investors identify specific niches and target markets. 

• Expert Analysis: Provides expert insights and forecasts from industry analysts

FAQ

What are insulin delivery devices?
Insulin delivery devices are medical devices used by individuals with diabetes to administer insulin, which helps control blood glucose levels. These devices include insulin pumps, pens, syringes, and inhaled insulin systems, as well as continuous glucose monitoring (CGM) devices that assist in more accurate and automated insulin administration.

What types of insulin delivery devices are available in the market?
The major types of insulin delivery devices are insulin pumps, insulin pens, insulin syringes, inhaled insulin devices, and continuous glucose monitoring (CGM) systems. Insulin pumps and CGMs are often used in combination to provide more automated, precise insulin delivery.

What are the main challenges in the insulin delivery devices market?
Challenges in the insulin delivery devices market include the high cost of advanced devices, regulatory hurdles for new technology, and the complexity of device integration and user training. Additionally, there are concerns about data security and privacy related to the use of connected devices for monitoring glucose levels.

What is the future outlook for insulin delivery devices in the US?
The future of insulin delivery devices looks promising, with ongoing advancements in technology, such as smarter insulin pumps, integrated wearable devices, and non-invasive insulin delivery methods. As diabetes rates continue to rise, there will likely be increased demand for more efficient, user-friendly solutions, and greater access to these devices through expanded insurance coverage.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

• 2.2 Criticality of inputs and factors of differentiation
  • Overview on criticality of inputs and factors of differentiation

• 2.3 Factors of disruption
  • Overview on factors of disruption

• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market

• 3.2 Market characteristics
  • Market characteristics analysis

• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition

• 4.2 Market segment analysis
  • Market segments

• 4.3 Market size 2024

• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global Market - Market size and forecast 2024-2029 ($ billion)
  • Data Table on Global Market - Market size and forecast 2024-2029 ($ billion)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Market 2019 - 2023
  • Historic Market Size - Data Table on Global Market 2019 - 2023 ($ billion)

• 5.2 Segment Analysis 2019 - 2023
  • Historic Market Size – Segment Analysis 2019 - 2023 ($ billion)

• 5.4 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

• 6.1 Impact of AI on the Global Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029

• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029

• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029

• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029

• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029

• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029

• 7.7 Market condition
  • Chart on market condition - Five forces 2024 and 2029

8 Market Segmentation

• 8.1 Market segments
  • Chart on Segmentation - Market share 2024-2029 (%)
  • Data Table on Segmentation - Market share 2024-2029 (%)

• 8.2 Segment Comparison
  • Chart on Comparison
  • Data Table on Comparison

• 8.3 Segment Market Opportunity
  • Market opportunity ($ billion)
  • Data Table on Market Opportunity ($ billion)

9 Customer Landscape

• 9.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

• 10.1 Geographic segmentation
  • Chart on market share by geography 2024-2029 (%)
  • Data Table on market share by geography 2024-2029 (%)

• 10.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison

• 10.3 Market opportunity by geography
  • Market opportunity by geography ($ billion)
  • Data Tables on Market opportunity by geography ($ billion)

11 Drivers, Challenges, and Opportunity/Restraints

• 11.1 Market drivers

• 11.2 Market challenges

• 11.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

• 11.4 Market opportunities/restraints

12 Competitive Landscape

• 12.1 Overview

• 12.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation

• 12.3 Landscape disruption
  • Overview on factors of disruption

• 12.4 Industry risks
  • Impact of key risks on business

13 Competitive Analysis

• 13.1 Companies profiled
  • Companies covered

• 13.2 Company ranking index
  • Company ranking index

• 13.3 Market positioning of companies
  • Matrix on companies position and classification

14 Appendix

• 14.1 Scope of the report

• 14.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist

• 14.3 Currency conversion rates for US$
  • Currency conversion rates for US$

• 14.4 Research methodology
  • Research methodology

• 14.5 Data procurement
  • Information sources

• 14.6 Data validation
  • Data validation

• 14.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing

• 14.8 Data synthesis
  • Data synthesis

• 14.9 360 degree market analysis
  • 360 degree market analysis

• 14.10 List of abbreviations
  • List of abbreviations